Holen Sie sich die Stockscreener-App
11.27
3.11%
0.34
Schlusskurs vom Vortag:
$10.93
Offen:
$11.02
24-Stunden-Volumen:
689.01K
Relative Volume:
0.54
Marktkapitalisierung:
$1.78B
Einnahmen:
$363.55M
Nettoeinkommen (Verlust:
$-78.68M
KGV:
93.92
EPS:
0.12
Netto-Cashflow:
$50.74M
1W Leistung:
+18.01%
1M Leistung:
+10.49%
6M Leistung:
-32.64%
1J Leistung:
-23.23%
1-Tages-Spanne:
$10.93
$11.32
1-Wochen-Bereich:
$9.41
$11.43
52-Wochen-Spanne:
$9.41
$19.87
Certara Inc Stock (CERT) Company Profile
Firmenname
Certara Inc
Sektor
Branche
Telefon
(415) 237-8272
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Vergleichen Sie CERT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
11.27 | 1.78B | 363.55M | -78.68M | 50.74M | 0.12 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-27 | Hochstufung | UBS | Neutral → Buy |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Eingeleitet | Berenberg | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-01 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-11 | Hochstufung | Jefferies | Hold → Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Neutral |
| 2021-01-05 | Eingeleitet | Jefferies | Hold |
| 2021-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Certara Inc Aktie (CERT) Neueste Nachrichten
Advantage Alpha Capital Partners LP Invests $1.88 Million in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Brown Brothers Harriman & Co. Takes Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Massachusetts Financial Services Co. MA Has $45.69 Million Holdings in Certara, Inc. (NASDAQ:CERT) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Acquires New Stake in Certara, Inc. (NASDAQ:CERT) - MarketBeat
CERT (Certara) Cash-to-Debt : 0.76 (As of Sep. 2024) - GuruFocus.com
CERT (Certara) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Current Deferred Taxes Liabilities : $0.0 Mil (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cyclically Adjusted Book per Share : $0.00 (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Peter Lynch Fair Value : N/A (As of Nov. 21, 2024) - GuruFocus.com
CERT (Certara) GF Score : 78/100 (As of Nov. 21, 2024) - GuruFocus.com
CERT (Certara) Net Income From Continuing Operations : $-31.1 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) 5-Year EBITDA Growth Rate : -0.90% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cash Flow from Operations : $54.4 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cash Flow from Investing : $-76.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) EBITDA : $55.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) 50-Day SMA : $10.82 (As of Nov. 20, 2024) - GuruFocus.com
CERT (Certara) Predictability Rank - GuruFocus.com
CERT (Certara) Future 3-5Y EPS without NRI Growth Rate : 11.29 (As of Nov. 20, 2024) - GuruFocus.com
CERT (Certara) Growth Rank : 9 (As of Nov. 20, 2024) - GuruFocus.com
CERT (Certara) Change In Receivables : $-17.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Earnings Yield % : N/A% (As of Nov. 20, 2024) - GuruFocus.com
CERT (Certara) Earnings per Share (Diluted) : $-0.20 (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cash From Discontinued Investing Activities : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cyclically Adjusted FCF per Share : $0.00 (As of Sep. 2024) - GuruFocus.com
CERT (Certara) 3-Year Revenue Growth Rate : 6.80% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cash Flow from Discontinued Operations : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) EBIT per Share : $-0.06 (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Revenue per Share : $2.33 (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) 3-Year EBITDA Growth Rate : 3.80% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Shares Outstanding (EOP) : 160.9 Mil (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Days Inventory : 0.00 (As of Sep. 2024) - GuruFocus.com
CERT (Certara) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Profitability Rank : 5 (As of Sep. 2024) - GuruFocus.com
Certara Inc (CERT) Q2 2024 Earnings: EPS of -$0.08 Misses Estima - GuruFocus.com
Certara price target lowered to $12 from $14 at Barclays - MSN
Leerink Partnrs Brokers Cut Earnings Estimates for Certara - MarketBeat
(CERT) Proactive Strategies - Stock Traders Daily
Certara (NASDAQ:CERT) Sets New 52-Week LowShould You Sell? - MarketBeat
Certara stock hits 52-week low at $9.98 amid market challenges - Investing.com
WASATCH ADVISORS LP Expands Stake in Certara Inc - GuruFocus.com
Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 - Insider Monkey
Certara's SWOT analysis: biosimulation firm navigates market shifts - Investing.com India
Certara's SWOT analysis: biosimulation firm navigates market shifts By Investing.com - Investing.com Australia
Certara, Inc. (NASDAQ:CERT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Certara (NASDAQ:CERT) Announces Earnings Results - MarketBeat
Certara, Inc. (NASDAQ:CERT) Q3 2024 Earnings Call Transcript - Insider Monkey
Forecasting The Future: 4 Analyst Projections For Certara - Benzinga
Certara (NASDAQ:CERT) Given New $12.00 Price Target at Barclays - MarketBeat
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com
Certara Reports Third Quarter 2024 Financial Results - The Manila Times
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Finanzdaten der Certara Inc-Aktie (CERT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):